- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 211/48 - Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
Patent holdings for IPC class C07D 211/48
Total number of patents in this class: 106
10-year publication summary
|
9
|
11
|
11
|
10
|
2
|
6
|
3
|
7
|
4
|
5
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pfizer Inc. | 3322 |
6 |
| Ono Pharmaceutical Co., Ltd. | 454 |
5 |
| Bristol-myers Squibb Company | 5080 |
4 |
| Theravance Biopharma R&D IP, LLC | 550 |
4 |
| Massachusetts Institute of Technology | 9795 |
3 |
| The Broad Institute, Inc. | 1584 |
3 |
| Chronos Therapeutics Limited | 19 |
3 |
| Cognition Therapeutics, Inc. | 33 |
3 |
| Gilead Sciences, Inc. | 1879 |
3 |
| Incyte Holdings Corporation | 609 |
3 |
| Teijin Pharma Limited | 258 |
3 |
| Grey Wolf Therapeutics Limited | 13 |
3 |
| AstraZeneca AB | 3042 |
2 |
| Agios Pharmaceuticals, Inc | 200 |
2 |
| DIC Corporation | 3597 |
2 |
| Elan Pharmaceuticals, Inc. | 69 |
2 |
| Lek Pharmaceuticals d.d. | 227 |
2 |
| Nagoya Industrial Science Research Institute | 36 |
2 |
| NHWA Pharma. Corporation | 52 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 155 |
2 |
| Other owners | 47 |